Advertisement
Review Article| Volume 44, ISSUE 1, P35-46, March 2023

Listing Dilemmas

Age, Frailty, Weight, Preexisting Cancers, and Systemic Diseases

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Benden C.
        • Edwards L.B.
        • Kucheryavaya A.Y.
        • et al.
        The registry of the international society for heart and lung transplantation: sixteenth official pediatric lung and heart-lung transplantation report--2013; focus theme: age.
        J Heart Lung Transpl. 2013; 32: 989-997
        • Medina L.D.
        • Sabo S.
        • Vespa J.
        Living longer: historical and projected life expectancy in the United States, 1960 to 2060.
        in: Current population reports. U.S. Census Bureau, 2020: 1125-1145
        • Avdimiretz N.
        • Benden C.
        The changing landscape of pediatric lung transplantation.
        Clin Transpl. 2022; 36: e14634
        • Chambers D.C.
        • Yusen R.D.
        • Cherikh W.S.
        • et al.
        The registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time.
        J Heart Lung Transpl. 2017; 36: 1047-1059
        • Colvin M.M.
        • Smith C.A.
        • Tullius S.G.
        • et al.
        Aging and the immune response to organ transplantation.
        J Clin Invest. 2017; 127: 2523-2529
        • Canales M.
        • Youssef P.
        • Spong R.
        • et al.
        Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation.
        Am J Transpl. 2006; 6: 2157-2163
        • Ojo A.O.
        • Held P.J.
        • Port F.K.
        • et al.
        Chronic renal failure after transplantation of a nonrenal organ.
        N Engl J Med. 2003; 349: 931-940
        • D'Angelo A.M.
        • Chan E.G.
        • Hayanga J.W.
        • et al.
        Atrial arrhythmias after lung transplantation: incidence and risk factors in 652 lung transplant recipients.
        J Thorac Cardiovasc Surg. 2016; 152: 901-909
        • Shtraichman O.
        • Ahya V.N.
        Malignancy after lung transplantation.
        Ann Transl Med. 2020; 8: 416
        • Biswas Roy S.
        • Alarcon D.
        • Walia R.
        • et al.
        Is there an age limit to lung transplantation?.
        Ann Thorac Surg. 2015; 100: 443-451
        • Lehr C.J.
        • Blackstone E.H.
        • McCurry K.R.
        • et al.
        Extremes of age decrease survival in adults after lung transplant.
        Chest. 2020; 157: 907-915
        • Mosher C.L.
        • Weber J.M.
        • Frankel C.W.
        • et al.
        Risk factors for mortality in lung transplant recipients aged ≥65 years: a retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients.
        J Heart Lung Transpl. 2021; 40: 42-55
        • Meyer D.M.
        • Edwards L.B.
        • Torres F.
        • et al.
        Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis.
        Ann Thorac Surg. 2005; 79 (; discussion 957-958): 950-957
        • Puri V.
        • Patterson G.A.
        • Meyers B.F.
        Single versus bilateral lung transplantation: do guidelines exist?.
        Thorac Surg Clin. 2015; 25: 47-54
        • Artz A.S.
        Biologic vs physiologic age in the transplant candidate.
        Hematol Am Soc Hematol Educ Program. 2016; 2016: 99-105
        • Wigfield C.H.
        • Buie V.
        • Onsager D.
        Age" in lung transplantation: factors related to outcomes and other considerations.
        Curr Pulmonol Rep. 2016; 5: 152-158
        • Genao L.
        • Whitson H.E.
        • Zaas D.
        • et al.
        Functional status after lung transplantation in older adults in the post-allocation score era.
        Am J Transpl. 2013; 13: 157-166
        • Singer J.P.
        • Katz P.P.
        • Soong A.
        • et al.
        Effect of lung transplantation on health-related quality of life in the era of the lung allocation score: a U.S. Prospective cohort study.
        Am J Transpl. 2017; 17: 1334-1345
        • Lawrence E.C.
        Ethical issues in lung transplantation.
        Am J Med Sci. 1998; 315: 142-145
      1. Network OPaT. Ethical principles in the allocation of human organs. In:2015.

        • Singer J.P.
        • Diamond J.M.
        • Anderson M.R.
        • et al.
        Frailty phenotypes and mortality after lung transplantation: a prospective cohort study.
        Am J Transpl. 2018; 18: 1995-2004
        • Wilson M.E.
        • Vakil A.P.
        • Kandel P.
        • et al.
        Pretransplant frailty is associated with decreased survival after lung transplantation.
        J Heart Lung Transpl. 2016; 35: 173-178
        • Rozenberg D.
        • Mathur S.
        • Wickerson L.
        • et al.
        Frailty and clinical benefits with lung transplantation.
        J Heart Lung Transpl. 2018; 37: 1245-1253
        • Schaenman J.M.
        • Diamond J.M.
        • Greenland J.R.
        • et al.
        Frailty and aging-associated syndromes in lung transplant candidates and recipients.
        Am J Transpl. 2021; 21: 2018-2024
        • Chen X.
        • Mao G.
        • Leng S.X.
        Frailty syndrome: an overview.
        Clin Interv Aging. 2014; 9: 433-441
        • Koons B.
        • Anderson M.R.
        • Smith P.J.
        • et al.
        The Intersection of aging and lung transplantation: its impact on transplant evaluation, outcomes, and clinical care.
        Curr Transplant Rep. 2022; 9: 149-159
        • Fried L.P.
        • Tangen C.M.
        • Walston J.
        • et al.
        Frailty in older adults: evidence for a phenotype.
        J Gerontol A Biol Sci Med Sci. 2001; 56: M146-M156
        • Dent E.
        • Kowal P.
        • Hoogendijk E.O.
        Frailty measurement in research and clinical practice: a review.
        Eur J Intern Med. 2016; 31: 3-10
        • Singer J.P.
        • Diamond J.M.
        • Gries C.J.
        • et al.
        Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation.
        Am J Respir Crit Care Med. 2015; 192: 1325-1334
        • Baldwin M.R.
        • Singer J.P.
        • Huang D.
        • et al.
        Refining low physical activity measurement improves frailty assessment in advanced lung disease and survivors of critical illness.
        Ann Am Thorac Soc. 2017; 14: 1270-1279
        • Singer J.P.
        • Blanc P.D.
        • Dean Y.M.
        • et al.
        Development and validation of a lung transplant-specific disability questionnaire.
        Thorax. 2014; 69: 445
        • Venado A.
        • McCulloch C.
        • Greenland J.R.
        • et al.
        Frailty trajectories in adult lung transplantation: a cohort study.
        J Heart Lung Transpl. 2019; 38: 699-707
        • Courtwright A.M.
        • Zaleski D.
        • Gardo L.
        • et al.
        Causes, preventability, and cost of unplanned rehospitalizations within 30 Days of discharge after lung transplantation.
        Transplantation. 2018; 102: 838-844
        • Halpern A.L.
        • Boshier P.R.
        • White A.M.
        • et al.
        A Comparison of frailty measures at listing to predict outcomes after lung transplantation.
        Ann Thorac Surg. 2020; 109: 233-240
        • Hsu J.
        • Krishnan A.
        • Lin C.T.
        • et al.
        Sarcopenia of the psoas muscles is associated with poor outcomes following lung transplantation.
        Ann Thorac Surg. 2019; 107: 1082-1088
        • Maheshwari J.A.
        • Kolaitis N.A.
        • Anderson M.R.
        • et al.
        Construct and predictive validity of sarcopenia in lung transplant candidates.
        Ann Am Thorac Soc. 2021; 18: 1464-1474
        • Cruz-Jentoft A.J.
        • Baeyens J.P.
        • Bauer J.M.
        • et al.
        Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people.
        Age and Ageing. 2010; 39: 412-423
        • Wilson D.
        • Jackson T.
        • Sapey E.
        • et al.
        Frailty and sarcopenia: the potential role of an aged immune system.
        Ageing Res Rev. 2017; 36: 1-10
        • Layton A.M.
        • Armstrong H.F.
        • Baldwin M.R.
        • et al.
        Frailty and maximal exercise capacity in adult lung transplant candidates.
        Respir Med. 2017; 131: 70-76
        • Makary M.A.
        • Segev D.L.
        • Pronovost P.J.
        • et al.
        Frailty as a predictor of surgical outcomes in older patients.
        J Am Coll Surg. 2010; 210: 901-908
        • Varughese R.A.
        • Theou O.
        • Li Y.
        • et al.
        Cumulative deficits frailty index predicts outcomes for solid organ transplant candidates.
        Transplant Direct. 2021; 7
        • Rozenberg D.
        • Singer L.G.
        • Herridge M.
        • et al.
        Evaluation of skeletal muscle function in lung transplant candidates.
        Transplantation. 2017; 101 (Paper presented at): 2183-2191
        • Montgomery E.
        • Macdonald P.S.
        • Newton P.J.
        • et al.
        Reversibility of frailty after lung transplantation.
        J Transpl. 2020; 2020: 3239495
        • Wickerson L.
        • Rozenberg D.
        • Janaudis-Ferreira T.
        • et al.
        Physical rehabilitation for lung transplant candidates and recipients: an evidence-informed clinical approach.
        World J Transpl. 2016; 6: 517-531
        • Li M.
        • Mathur S.
        • Chowdhury N.A.
        • et al.
        Pulmonary rehabilitation in lung transplant candidates.
        J Heart Lung Transpl. 2013; 32: 626-632
        • Langer D.
        Rehabilitation in patients before and after lung transplantation.
        Respiration. 2015; 89: 353-362
        • Singer J.P.
        • Soong A.
        • Bruun A.
        • et al.
        A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: a pilot study.
        Clin Transplant. 2018; 32: e13274
        • Kobashigawa J.
        • Dadhania D.
        • Bhorade S.
        • et al.
        Report from the American Society of Transplantation on frailty in solid organ transplantation.
        Am J Transpl. 2019; 19: 984-994
        • Singer J.P.
        • Peterson E.R.
        • Snyder M.E.
        • et al.
        Body composition and mortality after adult lung transplantation in the United States.
        Am J Respir Crit Care Med. 2014; 190: 1012-1021
        • Lederer D.J.
        • Wilt J.S.
        • D'Ovidio F.
        • et al.
        Obesity and underweight are associated with an increased risk of death after lung transplantation.
        Am J Respir Crit Care Med. 2009; 180: 887-895
        • Upala S.
        • Panichsillapakit T.
        • Wijarnpreecha K.
        • et al.
        Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis.
        Transpl Int. 2016; 29: 285-296
        • Jomphe V.
        • Mailhot G.
        • Damphousse V.
        • et al.
        The impact of waiting list BMI changes on the short-term outcomes of lung transplantation.
        Transplantation. 2018; 102: 318-325
        • Ramos K.J.
        • Kapnadak S.G.
        • Bradford M.C.
        • et al.
        Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united Network for organ sharing registry study.
        Chest. 2020; 157: 898-906
        • Leard L.E.
        • Holm A.M.
        • Valapour M.
        • et al.
        Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation.
        J Heart Lung Transpl. 2021; 40: 1349-1379
        • Centers for Disease Control and Prevention
        Adult obesity facts.
        (Available at:) (Accessed August 17, 2022)
        • World Health Organization
        Obesity and overweight.
        (Available at:) (Accessed August 17, 2022)
        • Chambers D.C.
        • Perch M.
        • Zuckermann A.
        • et al.
        The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult lung transplantation report - 2021; focus on recipient characteristics.
        J Heart Lung Transpl. 2021; 40: 1060-1072
        • Fernandez R.
        • Safaeinili N.
        • Kurihara C.
        • et al.
        Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score.
        J Thorac Cardiovasc Surg. 2018; 155: 1871-1879 e1873
        • Clausen E.S.
        • Frankel C.
        • Palmer S.M.
        • et al.
        Pretransplant weight loss and clinical outcomes after lung transplantation.
        J Heart Lung Transpl. 2018; 37: 1443-1447
        • Chandrashekaran S.
        • Keller C.A.
        • Kremers W.K.
        • et al.
        Weight loss prior to lung transplantation is associated with improved survival.
        J Heart Lung Transpl. 2015; 34: 651-657
        • Weill D.
        • Benden C.
        • Corris P.A.
        • et al.
        A consensus document for the selection of lung transplant candidates: 2014--an update from the pulmonary transplantation council of the international society for heart and lung transplantation.
        J Heart Lung Transpl. 2015; 34: 1-15
        • Shah N.R.
        • Braverman E.R.
        Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin.
        PloS one. 2012; 7: e33308
        • Romero-Corral A.
        • Somers V.K.
        • Sierra-Johnson J.
        • et al.
        Accuracy of body mass index in diagnosing obesity in the adult general population.
        Int J Obes (Lond). 2008; 32: 959-966
        • Kuk J.L.
        • Janiszewski P.M.
        • Ross R.
        Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference.
        Am J Clin Nutr. 2007; 85: 1540-1544
        • Considine R.V.
        • Sinha M.K.
        • Heiman M.L.
        • et al.
        Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
        N Engl J Med. 1996; 334: 292-295
        • Anderson M.R.
        • Udupa J.K.
        • Edwin E.
        • et al.
        Adipose tissue quantification and primary graft dysfunction after lung transplantation: the Lung Transplant Body Composition study.
        J Heart Lung Transpl. 2019; 38: 1246-1256
        • Whitson B.A.
        • Shelstad R.C.
        • Hertz M.I.
        • et al.
        Lung transplantation after hematopoietic stem cell transplantation.
        Clin Transpl. 2012; 26: 254-258
        • Van Raemdonck D.
        • Vos R.
        • Yserbyt J.
        • et al.
        Lung cancer: a rare indication for, but frequent complication after lung transplantation.
        J Thorac Dis. 2016; 8: S915-S924
        • Copur M.S.
        • Wurdeman J.M.
        • Nelson D.
        • et al.
        Normalization of elevated tumor marker CA27-29 after bilateral lung transplantation in a patient with breast cancer and idiopathic pulmonary fibrosis.
        Oncol Res. 2018; 26: 515-518
        • Beaty C.A.
        • George T.J.
        • Kilic A.
        • et al.
        Pretransplant malignancy: an analysis of outcomes after thoracic organ transplantation.
        J Heart Lung Transpl. 2013; 32: 202-211
        • Rudasill S.E.
        • Iyengar A.
        • Sanaiha Y.
        • et al.
        Pretransplant malignancy among lung transplant recipients in the modern era.
        Surgery. 2019; 165: 1228-1233
        • Kasiske B.L.
        • Cangro C.B.
        • Hariharan S.
        • et al.
        The evaluation of renal transplantation candidates: clinical practice guidelines.
        Am J Transpl. 2001; 1: 3-95
        • Penn I.
        Evaluation of the candidate with a previous malignancy.
        Liver Transpl Surg. 1996; 2: 109-113
        • Orens J.B.
        • Estenne M.
        • Arcasoy S.
        • et al.
        International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the pulmonary scientific council of the international society for heart and lung transplantation.
        J Heart Lung Transpl. 2006; 25: 745-755
        • Sekowski V.
        • Jackson K.
        • Halloran K.
        • et al.
        Pretransplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation.
        Respir Med. 2022; 197: 106855
        • Parada M.T.
        • Sepulveda C.
        • Alba A.
        • et al.
        Malignancy development in lung transplant patients.
        Transpl Proc. 2011; 43: 2316-2317
        • Al-Adra D.P.
        • Hammel L.
        • Roberts J.
        • et al.
        Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement.
        Am J Transpl. 2021; 21: 460-474
        • Al-Adra D.P.
        • Hammel L.
        • Roberts J.
        • et al.
        Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement.
        Am J Transpl. 2021; 21: 475-483
        • Nair N.
        • Gongora E.
        • Mehra M.R.
        Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance?.
        J Heart Lung Transpl. 2014; 33: 461-467
        • Campistol J.M.
        • Cuervas-Mons V.
        • Manito N.
        • et al.
        New concepts and best practices for management of pre- and posttransplantation cancer.
        Transpl Rev (Orlando). 2012; 26: 261-279
        • Engels E.A.
        • Pfeiffer R.M.
        • Fraumeni Jr., J.F.
        • et al.
        Spectrum of cancer risk among US solid organ transplant recipients.
        JAMA. 2011; 306: 1891-1901
        • Krisl J.C.
        • Doan V.P.
        Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients.
        Am J Transpl. 2017; 17: 1974-1991
        • Katabathina V.S.
        • Menias C.O.
        • Tammisetti V.S.
        • et al.
        Malignancy after solid organ transplantation: comprehensive imaging review.
        Radiographics. 2016; 36: 1390-1407
        • Dantal J.
        • Soulillou J.P.
        Immunosuppressive drugs and the risk of cancer after organ transplantation.
        N Engl J Med. 2005; 352: 1371-1373
        • Noone A.M.
        • Pfeiffer R.M.
        • Dorgan J.F.
        • et al.
        Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014.
        Cancer. 2019; 125: 2647-2655
        • Billups K.
        • Neal J.
        • Salyer J.
        Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant.
        Prog Transpl. 2015; 25: 182-188
        • Rudasill S.E.
        • Iyengar A.
        • Sanaiha Y.
        • et al.
        Donor history of malignancy: a limited risk for heart transplant recipients.
        Clin Transpl. 2020; 34: e13762
        • Bennett D.
        • Fossi A.
        • Refini R.M.
        • et al.
        Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature.
        Tumori. 2016; 102: 574-581
        • Acuna S.A.
        • Huang J.W.
        • Dossa F.
        • et al.
        Cancer recurrence after solid organ transplantation: a systematic review and meta-analysis.
        Transpl Rev (Orlando). 2017; 31: 240-248
        • Acuna S.A.
        • Sutradhar R.
        • Kim S.J.
        • et al.
        Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study.
        Transplantation. 2018; 102: 1156-1164
        • Brattstrom C.
        • Granath F.
        • Edgren G.
        • et al.
        Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history.
        Transplantation. 2013; 96: 297-305
        • Antin-Ozerkis D.
        • Highland K.B.
        Thoracic manifestations of rheumatic disease.
        Clin Chest Med. 2019; 40 (xiii)
        • Lee J.C.
        • Ahya V.N.
        Lung transplantation in autoimmune diseases.
        Clin Chest Med. 2010; 31: 589-603
        • Chambers D.C.
        • Cherikh W.S.
        • Harhay M.O.
        • et al.
        The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match.
        J Heart Lung Transpl. 2019; 38: 1042-1055
        • Courtwright A.M.
        • El-Chemaly S.
        • Dellaripa P.F.
        • et al.
        Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.
        J Heart Lung Transpl. 2017; 36: 763-769
        • Crespo M.M.
        • Bermudez C.A.
        • Dew M.A.
        • et al.
        Lung transplant in patients with scleroderma compared with pulmonary fibrosis: short- and long-term outcomes.
        Ann Am Thorac Soc. 2016; 13: 784-792
        • Khan I.Y.
        • Singer L.G.
        • de Perrot M.
        • et al.
        Survival after lung transplantation in systemic sclerosis. A systematic review.
        Respir Med. 2013; 107: 2081-2087
        • Bernstein E.J.
        • Bathon J.M.
        • Lederer D.J.
        Survival of adults with systemic autoimmune rheumatic diseases and pulmonary arterial hypertension after lung transplantation.
        Rheumatology (Oxford). 2018; 57: 831-834
        • Bernstein E.J.
        • Peterson E.R.
        • Sell J.L.
        • et al.
        Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study.
        Arthritis Rheumatol. 2015; 67: 1314-1322
        • Natalini J.G.
        • Diamond J.M.
        • Porteous M.K.
        • et al.
        Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
        J Heart Lung Transpl. 2021; 40: 351-358
        • Crespo M.M.
        • Lease E.D.
        • Sole A.
        • et al.
        ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements.
        J Heart Lung Transpl. 2021; 40: 1251-1266
        • McInnes I.B.
        • Schett G.
        The pathogenesis of rheumatoid arthritis.
        N Engl J Med. 2011; 365: 2205-2219
        • van den Hoogen F.
        • Khanna D.
        • Fransen J.
        • et al.
        2013 Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
        Ann Rheum Dis. 2013; 72: 1747-1755
        • Solomon J.J.
        • Olson A.L.
        • Fischer A.
        • et al.
        Scleroderma lung disease.
        Eur Respir Rev. 2013; 22: 6-19